| scholarly article | Q13442814 |
| P50 | author | Thomas Decaens | Q62096202 |
| Olivier Boillot | Q33241170 | ||
| Philippe Mathurin | Q54835963 | ||
| Francois Durand | Q55187615 | ||
| Alexandre Louvet | Q56927394 | ||
| Emmanuel Boleslawski | Q57564778 | ||
| P2093 | author name string | Christophe Duvoux | |
| Carole Meyer | |||
| Jean Gugenheim | |||
| Valérie Canva | |||
| Géraldine Sergent | |||
| Olivier Ernst | |||
| Sébastien Dharancy | |||
| Nicole Declerck | |||
| Claire Vanlemmens | |||
| Jeanne Boitard | |||
| Olivier Romano | |||
| François René Pruvot | |||
| P2860 | cites work | Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation | Q39396021 |
| P433 | issue | 5 | |
| P921 | main subject | liver transplantation | Q1368191 |
| P304 | page(s) | 665-671 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Liver Transplantation | Q15730498 |
| P1476 | title | Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study | |
| P478 | volume | 13 |
| Q37634987 | Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: hepatocellular carcinoma: imaging in assessing treatment efficacy |
| Q40450035 | Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma. |
| Q34065055 | Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant list. |
| Q57782407 | Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation |
| Q38032905 | Current status of hepatocellular carcinoma treatment in Japan: transarterial chemoembolization |
| Q50784548 | Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinoma. |
| Q56985915 | Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas |
| Q37353089 | Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma |
| Q26783881 | Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols |
| Q46291005 | Hepatocellular carcinomas within the Milan criteria: predictors of histologic necrosis after drug-eluting beads transarterial chemoembolization |
| Q37598642 | Liver transplantation for hepatocellular carcinoma: current topics in France |
| Q82845317 | Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? |
| Q51747220 | Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma |
| Q27005375 | Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation |
| Q37300023 | TACE versus TAE as therapy for hepatocellular carcinoma |
| Q35096101 | The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration review of 2011 |
| Q53232389 | Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival. |
Search more.